FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193600518> ?p ?o ?g. }

• W3193600518 endingPage "e653" @default.
• W3193600518 startingPage "e644" @default.
• W3193600518 abstract "BackgroundSince the benefit–harm balance of adding inhaled corticosteroids to long-acting β2-agonists (LABA) and long-acting muscarinic antagonists (LAMA) for patients with chronic obstructive pulmonary disease is unclear, we evaluated this addition for a range of patient profiles.MethodsAnalyses considered the effects of low-to-moderate doses of inhaled corticosteroids, LABA, and LAMA compared with LABA and LAMA alone, outcome incidences, and preference weights assigned to averted moderate-to-severe exacerbations (benefit) and severe pneumonia, candidiasis, and dysphonia (harm). Using exponential models, we estimated the preference weight-adjusted 2-year net clinical benefit (ie, benefits outweighing harms) indices. Exacerbation risk thresholds for triggering inhaled corticosteroids, LABA, and LAMA were established when the probability of a 2-year net clinical benefit reached 60%. We estimated the proportion of patients benefiting from added inhaled corticosteroids using an externally validated prediction model for acute exacerbations in primary care.FindingsAdding low-to-moderate dose inhaled corticosteroids to LABA and LAMA provided a net clinical benefit in patients with a 2-year baseline exacerbation risk of 54–83%. Low-dose inhaled corticosteroids showed a net clinical benefit if the baseline risk was 40–91%, but not at higher doses. The benefit was modified by blood eosinophil count (BEC) and age. Although no net benefit was associated with a BEC of less than 150 cells per μL, patients with a BEC of 150 cells per μL or more had a net benefit from low-dose inhaled corticosteroids with a 2-year exacerbation risk of 32–95% in those aged 40–79 years and 41–93% in those older than 80 years. A moderate dose of inhaled corticosteroids showed a net benefit in patients younger than 80 years with a BEC of 150 cells per μL or more at 52–86% 2-year exacerbation risk. Depending on the subgroups, the proportion of patients with a net benefit from added inhaled corticosteroids ranged from 0 to 68%.InterpretationThe net clinical benefit of adding different inhaled corticosteroid doses to LABA and LAMA varies greatly with exacerbation risk, BEC, and age. Personalised treatment decisions based on these factors and predicted exacerbation risks might reduce overtreatment and undertreatment with inhaled corticosteroids.FundingNone." @default.
• W3193600518 created "2021-08-30" @default.
• W3193600518 creator A5043266322 @default.
• W3193600518 creator A5044501489 @default.
• W3193600518 creator A5054105827 @default.
• W3193600518 creator A5065910811 @default.
• W3193600518 creator A5083315765 @default.
• W3193600518 creator A5083975390 @default.
• W3193600518 date "2021-10-01" @default.
• W3193600518 modified "2023-10-07" @default.
• W3193600518 title "Personalising add-on treatment with inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a benefit–harm modelling study" @default.
• W3193600518 cites W1984045504 @default.
• W3193600518 cites W1987881697 @default.
• W3193600518 cites W1994535720 @default.
• W3193600518 cites W2000894790 @default.
• W3193600518 cites W2001104945 @default.
• W3193600518 cites W2057984874 @default.
• W3193600518 cites W2058580481 @default.
• W3193600518 cites W2080886948 @default.
• W3193600518 cites W2104636056 @default.
• W3193600518 cites W2115987911 @default.
• W3193600518 cites W2120629366 @default.
• W3193600518 cites W2124103690 @default.
• W3193600518 cites W2133986277 @default.
• W3193600518 cites W2148644252 @default.
• W3193600518 cites W2167941825 @default.
• W3193600518 cites W2170298115 @default.
• W3193600518 cites W2208461822 @default.
• W3193600518 cites W2466769091 @default.
• W3193600518 cites W2521232009 @default.
• W3193600518 cites W2604501983 @default.
• W3193600518 cites W2748958906 @default.
• W3193600518 cites W2783705291 @default.
• W3193600518 cites W2785999277 @default.
• W3193600518 cites W2802221596 @default.
• W3193600518 cites W2891482814 @default.
• W3193600518 cites W2898605444 @default.
• W3193600518 cites W2902104113 @default.
• W3193600518 cites W2982245275 @default.
• W3193600518 cites W2998646242 @default.
• W3193600518 cites W3011041697 @default.
• W3193600518 cites W3016201212 @default.
• W3193600518 cites W3037411127 @default.
• W3193600518 cites W3085049470 @default.
• W3193600518 doi "https://doi.org/10.1016/s2589-7500(21)00130-8" @default.
• W3193600518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34452874" @default.
• W3193600518 hasPublicationYear "2021" @default.
• W3193600518 type Work @default.
• W3193600518 sameAs 3193600518 @default.
• W3193600518 citedByCount "7" @default.
• W3193600518 countsByYear W31936005182022 @default.
• W3193600518 countsByYear W31936005182023 @default.
• W3193600518 crossrefType "journal-article" @default.
• W3193600518 hasAuthorship W3193600518A5043266322 @default.
• W3193600518 hasAuthorship W3193600518A5044501489 @default.
• W3193600518 hasAuthorship W3193600518A5054105827 @default.
• W3193600518 hasAuthorship W3193600518A5065910811 @default.
• W3193600518 hasAuthorship W3193600518A5083315765 @default.
• W3193600518 hasAuthorship W3193600518A5083975390 @default.
• W3193600518 hasBestOaLocation W31936005181 @default.
• W3193600518 hasConcept C126322002 @default.
• W3193600518 hasConcept C2776780178 @default.
• W3193600518 hasConcept C2776954882 @default.
• W3193600518 hasConcept C2777014857 @default.
• W3193600518 hasConcept C2780911369 @default.
• W3193600518 hasConcept C42219234 @default.
• W3193600518 hasConcept C71924100 @default.
• W3193600518 hasConceptScore W3193600518C126322002 @default.
• W3193600518 hasConceptScore W3193600518C2776780178 @default.
• W3193600518 hasConceptScore W3193600518C2776954882 @default.
• W3193600518 hasConceptScore W3193600518C2777014857 @default.
• W3193600518 hasConceptScore W3193600518C2780911369 @default.
• W3193600518 hasConceptScore W3193600518C42219234 @default.
• W3193600518 hasConceptScore W3193600518C71924100 @default.
• W3193600518 hasFunder F4320323874 @default.
• W3193600518 hasIssue "10" @default.
• W3193600518 hasLocation W31936005181 @default.
• W3193600518 hasLocation W31936005182 @default.
• W3193600518 hasOpenAccess W3193600518 @default.
• W3193600518 hasPrimaryLocation W31936005181 @default.
• W3193600518 hasRelatedWork W2061814643 @default.
• W3193600518 hasRelatedWork W2346277111 @default.
• W3193600518 hasRelatedWork W2767263702 @default.
• W3193600518 hasRelatedWork W2894474424 @default.
• W3193600518 hasRelatedWork W2950569478 @default.
• W3193600518 hasRelatedWork W2951336120 @default.
• W3193600518 hasRelatedWork W3047434665 @default.
• W3193600518 hasRelatedWork W3047874532 @default.
• W3193600518 hasRelatedWork W4230984066 @default.
• W3193600518 hasRelatedWork W4248150072 @default.
• W3193600518 hasVolume "3" @default.
• W3193600518 isParatext "false" @default.
• W3193600518 isRetracted "false" @default.
• W3193600518 magId "3193600518" @default.
• W3193600518 workType "article" @default.